Search research articles
Contact Us
Filters
Showing results (101-110 of 122) with videos related to
Page
of 13
Sort By:
British Journal of Haematology
|
March 6, 2019
Clinical features, laboratory characteristics and outcomes of patients with renal versus cardiac light chain amyloidosis
Surbhi Sidana, Nidhi Tandon, Morie A Gertz, et al.
Human Pathology
|
March 11, 2023
Mass spectrometry-based assessment of prostate cancer-associated crystalloids reveals enrichment for growth and differentiation factor 15
Burak Tekin, Surendra Dasari, Jason D Theis, et al.
Leukemia
|
November 28, 2019
Revisiting complete response in light chain amyloidosis
Surbhi Sidana, Angela Dispenzieri, David L Murray, et al.
Leukemia
|
June 17, 2024
Correction: Value of bone marrow examination in determining response to therapy in patients with multiple myeloma in the context of mass spectrometry-based M-protein assessment
Jean-Sébastien Claveau, David L Murray, Angela Dispenzieri, et al.
Leukemia
|
December 9, 2022
Value of bone marrow examination in determining response to therapy in patients with multiple myeloma in the context of mass spectrometry-based M-protein assessment
Jean-Sébastien Claveau, David L Murray, Angela Dispenzieri, et al.
Blood Advances
|
January 25, 2020
Utility of serum free light chain ratio in response definition in patients with multiple myeloma
Nadine Abdallah, Prashant Kapoor, David L Murray, et al.
Mayo Clinic Proceedings
|
August 8, 2016
Thrombotic Microangiopathy Care Pathway: A Consensus Statement for the Mayo Clinic Complement Alternative Pathway-Thrombotic Microangiopathy (CAP-TMA) Disease-Oriented Group
Ronald S Go, Jeffrey L Winters, Nelson Leung, et al.
British Journal of Haematology
|
November 20, 2020
Implications of detecting serum monoclonal protein by MASS-fix following stem cell transplantation in multiple myeloma
Jithma P Abeykoon, David L Murray, Isaiah Murray, et al.
Analytical Chemistry
|
May 27, 2016
Using Mass Spectrometry to Quantify Rituximab and Perform Individualized Immunoglobulin Phenotyping in ANCA-Associated Vasculitis
John R Mills, Divi Cornec, Surendra Dasari, et al.
Leukemia
|
November 30, 2019
IgM AL amyloidosis: delineating disease biology and outcomes with clinical, genomic and bone marrow morphological features
Surbhi Sidana, Daniel P Larson, Patricia T Greipp, et al.
Page
of 13
Search research articles
Search
Showing results (101-110 of 122) with videos related to
Sort By:
Page
of 13
British Journal of Haematology
|
March 6, 2019
Clinical features, laboratory characteristics and outcomes of patients with renal versus cardiac light chain amyloidosis
Surbhi Sidana, Nidhi Tandon, Morie A Gertz, et al.
Human Pathology
|
March 11, 2023
Mass spectrometry-based assessment of prostate cancer-associated crystalloids reveals enrichment for growth and differentiation factor 15
Burak Tekin, Surendra Dasari, Jason D Theis, et al.
Leukemia
|
November 28, 2019
Revisiting complete response in light chain amyloidosis
Surbhi Sidana, Angela Dispenzieri, David L Murray, et al.
Leukemia
|
June 17, 2024
Correction: Value of bone marrow examination in determining response to therapy in patients with multiple myeloma in the context of mass spectrometry-based M-protein assessment
Jean-Sébastien Claveau, David L Murray, Angela Dispenzieri, et al.
Leukemia
|
December 9, 2022
Value of bone marrow examination in determining response to therapy in patients with multiple myeloma in the context of mass spectrometry-based M-protein assessment
Jean-Sébastien Claveau, David L Murray, Angela Dispenzieri, et al.
Blood Advances
|
January 25, 2020
Utility of serum free light chain ratio in response definition in patients with multiple myeloma
Nadine Abdallah, Prashant Kapoor, David L Murray, et al.
Mayo Clinic Proceedings
|
August 8, 2016
Thrombotic Microangiopathy Care Pathway: A Consensus Statement for the Mayo Clinic Complement Alternative Pathway-Thrombotic Microangiopathy (CAP-TMA) Disease-Oriented Group
Ronald S Go, Jeffrey L Winters, Nelson Leung, et al.
British Journal of Haematology
|
November 20, 2020
Implications of detecting serum monoclonal protein by MASS-fix following stem cell transplantation in multiple myeloma
Jithma P Abeykoon, David L Murray, Isaiah Murray, et al.
Analytical Chemistry
|
May 27, 2016
Using Mass Spectrometry to Quantify Rituximab and Perform Individualized Immunoglobulin Phenotyping in ANCA-Associated Vasculitis
John R Mills, Divi Cornec, Surendra Dasari, et al.
Leukemia
|
November 30, 2019
IgM AL amyloidosis: delineating disease biology and outcomes with clinical, genomic and bone marrow morphological features
Surbhi Sidana, Daniel P Larson, Patricia T Greipp, et al.
Page
of 13